Cumberland Pharmaceuticals, Inc. (CPIX)

[surf1944]

7:11AM Cumberland Pharma announces Caldolor reduces pain and fever in adult patients; Studies support shortened Caldolor infusion time (CPIX) 4.51 : Co announced top-line results from two registry studies evaluating the safety and efficacy of Caldolor Injection administered over a shortened infusion time in treating pain and fever in adult patients. The studies involved 450 patients receiving Caldolor at 35 leading medical centers throughout the United States. The first of two registry studies was a phase IV multi-center, open-label surveillance clinical study to assess the safety and efficacy of ibuprofen administered intravenously over five to ten minutes to adult patients in the hospital setting with temperature fever and/or pain of intravenous ibuprofen for up to a 24-hour dosing period. One hundred fifty patients from 13 clinical sites were enrolled in this study. Intravenous ibuprofen reduced fever and pain and the shortened infusion time was well tolerated.